Home About us Services Contact
 

News

This achievement marks a crucial step forward for Eco Buildings Group, as it continues to expand its presence in the European market. The company's focus on prefabricated building solutions presents an attractive opportunity for investors seeking exposure to the growing construction sector. As ECOB.L continues to execute its development plans, shar...
Full article
23/06/2026 | Eco Buildings Group plc
Eco Buildings Group (ECOB.L) has made significant progress with its prefab building system, completing the second floor of its first apartment block in Albania. This milestone demonstrates the scalability of the company's system, which is expected to generate around €2.2 million in revenue upon completion. The project also lays the groundwork for f...
Full article
23/06/2026 | Eco Buildings Group plc
The High Court of Justice of England and Wales has approved Eli Lilly’s acquisition of Centessa Pharmaceuticals for roughly $7.8 billion. Under the agreement, Centessa shareholders will receive $38 in cash per share plus a contingent value right (CVR) that may pay up to an additional $9 per share if three milestones are met. The deal will be exec...
Full article
23/06/2026 | Centessa Pharmaceuticals plc
Rayonier Advanced Materials’ Board appointed Daniel Krawczyk as chief executive officer and president, effective immediately. Krawczyk, formerly president of Huber Engineered Materials, will also join the board and oversee the company’s operations while working with directors and external advisors in the ongoing review of strategic alternatives. Th...
Full article
23/06/2026 | Rayonier Advanced Materials Inc.
The company's volunteer efforts are ongoing throughout the year, reflecting SoCalGas's continued focus on delivering value to customers and strengthening the communities it serves. As a subsidiary of Sempra (NYSE: SRE), SoCalGas is the largest gas‑distribution utility in the United States, serving more than 21 million consumers across Central and S...
Full article
23/06/2026 | Southern California Gas Company PFD SER A 6%
The volunteer efforts complemented SoCalGas's broader commitment to helping customers manage energy costs through assistance programs, energy‑efficiency resources, and community projects. Employees supported organizations such as the Los Angeles Regional Food Bank, Orange County Food Bank, and The Salvation Army, among others. These collaborations...
Full article
23/06/2026 | Southern California Gas Company PFD SER A 6%
SoCalGas employees dedicated over 1,100 volunteer hours in May through the Glad to be of service initiative, equivalent to 27 full‑time workweeks. These efforts supported 57 nonprofit organizations across 38 cities and nine counties, focusing on critical needs such as food access, housing support, workforce readiness, and services for seniors and v...
Full article
23/06/2026 | Southern California Gas Company PFD SER A 6%
Text body: Verrica Pharmaceuticals (VRCA) said Monday that the first US patient has been dosed in the COVE-3 second clinical trial in its global phase 3 program evaluating Ycanth to treat common warts. The company said the trial is evaluating the efficacy and safety of Ycanth when applied once every 21 days for a up to four applications in patients...
Full article
23/06/2026 | Verrica Pharmaceuticals Inc.
The market opportunity for common warts is substantial, with approximately 22 million patients in the U.S. alone and no FDA-approved therapies currently available. If YCANTH is successfully developed, approved, and commercialized, it could represent a multibillion-dollar commercial opportunity for Verrica.
Full article
23/06/2026 | Verrica Pharmaceuticals Inc.
Verrica's Japanese development partner, Torii Pharmaceutical, will split the costs of the global Phase 3 program with Verrica on a 50/50 basis. This partnership demonstrates Verrica's commitment to addressing the significant unmet need for common wart treatments worldwide.
Full article
23/06/2026 | Verrica Pharmaceuticals Inc.